Author: franperez66q@protonmail.com

The Federal Reserve will hike rates by 25 basis points three times this year, according to PGIM, which is well outside the consensus for rates to stay even or see one hike by year-end. Economic resilience in the U.S. economy, inflation risks and renewed strength in the labor market will push the central bank to make those moves, PGIM said, adding that America is now facing high inflation with upside risks, as the U.S. Core Personal Consumption Expenditures price index is “uncomfortably high” at 3.3%. The Fed is in focus ahead of its meeting this week, to be helmed by…

Read More

Gold prices have undergone a “reset” during the Iran war, according to Barclays, which is anticipating a rebound as an end is in sight. Though spot gold rose 3.2% on Monday to $4,375 per ounce, its highest level since June 9, it remains over 20% below its January peak of over $5,589 per ounce. The war brought the metal’s safe-haven status into question, as the prospect of higher interest rates made yielding assets, like bonds, more attractive. In a note published on Monday, Barclays wrote it remains constructive on gold, saying “persistent inflation, policy uncertainty and central bank reserve diversification”…

Read More

Qualcomm is working on over 40 designs of new AI devices, CEO Cristiano Amon told CNBC, as the chip designer prepares for a wave of “agents” across consumer electronics.In a wide-ranging interview on CNBC’s “The Tech Download” podcast, Amon laid out his views on the changing role of smartphones and apps, why smart glasses could be the next major consumer device, new types of electronics that will hit the market, and how chip architectures will need to change for even smaller gadgets.Amon’s comments, which also alluded to new entrants in the consumer market, could have implications for the way major…

Read More

Public markets are beginning to reopen for biotech companies after several years of muted activity. But the strongest companies may still be more likely to sell themselves to Big Pharma rather than testing investor appetite in an IPO, according to JPMorgan’s top healthcare dealmakers.The IPO window has reopened for high-quality biotech companies, but investors are far more selective than they were during the pandemic-era boom, Juha Anjala and Roy Wouters, co-heads of JPMorgan’s EMEA healthcare investment banking, told CNBC. The current market is also prompting many biotech companies to pursue a dual-track process: preparing for an IPO while simultaneously engaging with…

Read More

Michele Bullock, governor of the Reserve Bank of Australia (RBA), attends a news conference at the bank’s head office in Sydney, Australia, on Tuesday, Dec. 9, 2025. Australia’s central bank kept its key interest rate unchanged for a third straight meeting in a widely expected decision, while reiterating that future moves will hinge on incoming economic data. Photographer: Brendon Thorne/Bloomberg via Getty ImagesBloomberg | Bloomberg | Getty ImagesThe Reserve Bank of Australia held rates at 4.35% Tuesday, while stating that it was ready to raise rates to manage price stability and full employment.The unanimous move was in line with economists…

Read More